Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries

Current Opinion in Gastroenterology

Volumn 31, Issue 1, 2015, Pages 1-6

  Schnadower, David ^a   Finkelstein, Yaron ^b   Freedman, Stephen B ^c  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acute gastroenteritis; Children; Ondansetron; Outpatient; Probiotics

Indexed keywords

BICARBONATE; DOMPERIDONE; ONDANSETRON; PROBIOTIC AGENT; ANTIEMETIC AGENT;

ACUTE GASTROENTERITIS; BACILLUS PUMILUS; BICARBONATE BLOOD LEVEL; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CLOSTRIDIUM BUTYRICUM; DEVELOPED COUNTRY; DISEASE SEVERITY; EMERGENCY WARD; ENTEROCOCCUS FAECALIS; HOSPITAL ADMISSION; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS REUTERI; LENGTH OF STAY; MEDICAL DECISION MAKING; META ANALYSIS (TOPIC); OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHYDRATION; REVIEW; VOMITING; ACUTE DISEASE; CHILD; GASTROENTERITIS; MULTIMODALITY CANCER THERAPY; OUTPATIENT DEPARTMENT;

ACUTE DISEASE; ANTIEMETICS; CHILD; COMBINED MODALITY THERAPY; DEVELOPED COUNTRIES; GASTROENTERITIS; HUMANS; ONDANSETRON; OUTPATIENT CLINICS, HOSPITAL; PROBIOTICS;

EID: 84916894038     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0000000000000132     Document Type: Review

References (62)

1. WHO. Fact Sheet N330 Diarrhoeal Disease 2013 [updated April 2013; cited 2 May 2014]. http://www.who.int/mediacentre/factsheets/fs330/en/.
2. Farthing M, Salam MA, Lindberg G, et al. Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol 2013; 47:12-20.
3. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209-222.
4. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since. Lancet 2012; 379:2151-2161.
5. CDC. CDC Estimates of Foodborne Illness in the United States 2011 [cited 2 May 2014]. http://www.cdc.gov/foodborneburden/2011-foodborne-estimates.html.
6. Freedman SB, Steiner MJ, Chan KJ. Oral ondansetron administration in emergency departments to children with gastroenteritis: an economic analysis. PLoS Med 2010; 7:e1000350.
7. Leshem E, Moritz RE, Curns AT, et al. Rotavirus vaccines and healthcare utilization for diarrhea in the United States. Pediatrics 2014; 134:15-23.
8. Freedman SB, Hall M, Shah SS, et al. Impact of increasing ondansetron use on clinical outcomes in children with gastroenteritis. JAMA Pediatr 2014; 168:321-329.
9. Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121-1130.
10. Patel MM, Widdowson MA, Glass RI, et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008; 14:1224-1231.
11. Freedman SB, Ali S, OleszczukM, et al. Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries. Evid Based Child Health 2013; 8:1123-1137.
12. Niescierenko M, Bachur R. Advances in pediatric dehydration therapy. Curr Opin Pediatr 2013; 25:304-309.
13. King CK, Glass R, Bresee JS, et al., Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003; 52:1-16.
14. Practice parameter: the management of acute gastroenteritis in young children. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Pediatrics 1996; 97:424-435.
15. Leung AP, Prince T. Oral rehydration therapy and early refeeding in the management of childhood gastroenteritis. Paediatr Child Health 2006; 11:527-531.
16. Guarino A, Ashkenazi S, Gendrel D, et al. European society for paediatric gastroenterology, hepatology, and nutrition/european society for paediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in europe: update 2014. J Pediatr Gastroenterol Nutr 2014; 59:132-152.
17. van den Berg J, Berger MY. Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care. BMC Fam Pract 2011; 12:134.
18. Kharbanda AB, Hall M, Shah SS, et al. Variation in resource utilization across a national sample of pediatric emergency departments. J Pediatr 2013; 163:230-236.
19. Freedman SB, Gouin S, Bhatt M, et al. Prospective assessment of practice pattern variations in the treatment of pediatric gastroenteritis. Pediatrics 2011; 127:e287-e295.
20. Nunez J, Liu DR, Nager AL. Dehydration treatment practices among pediatrics- trained and nonpediatrics trained emergency physicians. Pediatr Emerg Care 2012; 28:322-328.
21. Rerksuppaphol S, Rerksuppaphol L. Randomized study of ondansetron versus domperidone in the treatment of children with acute gastroenteritis. J Clin Med Res 2013; 5:460-466.
22. Keren R. Ondansetron for acute gastroenteritis: a failure of knowledge translation. JAMA Pediatr 2014; 168:308-309.
23. Freedman SB, DeGroot JM, Parkin PC. Successful discharge of children with gastroenteritis requiring intravenous rehydration. J Emerg Med 2014; 46:9-20.
24. Freedman SB, Powell E, Seshadri R. Predictors of outcomes in pediatric enteritis: a prospective cohort study. Pediatrics 2009; 123:e9-e16.
25. Freedman SB, Thull-Freedman JD, Rumantir M, et al. Emergency department revisits in children with gastroenteritis. J Pediatr Gastroenterol Nutr 2013; 57:612-618.
26. Mullarkey C, Crowley E, Martin C. The addition of ondansetron to a oral rehydration protocol for children with acute gastroenteritis. Ir Med J 2013; 106:266-268.
27. Patel AB, Dibley MJ, Mamtani M, et al. Influence of zinc supplementation in acute diarrhea differs by the isolated organism. Int J Pediatr 2010; 2010:671587.
28. Freedman SB, Uleryk E, Rumantir M, Finkelstein Y. Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis. Ann Emerg Med 2013; 64:19-25.
29. Salminen S, Ouwehand A, Benno Y, Lee YK. Probiotics: how should they be defined? Trend Food Sci Technol 1999; 10:107-110.
30. Ianiro G, Bibbo S, Gasbarrini A, Cammarota G. Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. Curr Drug Targets 2014; 15:762-770.
31. Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 2012; 160:246-257.
32. Lomax AR, Calder PC. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des 2009; 15:1428-1518.
33. Ng SC, Hart AL, Kamm MA, et al. Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 2009; 15:300-310.
34. Li ST, Klein EJ, Tarr PI, Denno DM. Parental management of childhood diarrhea. Clin Pediatr (Phila) 2009; 48:295-303.
35. Freedman SB, Sivabalasundaram V, Bohn V, et al. The treatment of pediatric gastroenteritis: a comparative analysis of pediatric emergency physicians' practice patterns. Acad Emerg Med 2011; 18:38-45.
36. Hoffmann DE, Fraser CM, Palumbo FB, et al. Science and regulation. Probiotics: finding the right regulatory balance. Science 2013; 342:314-315.
37. Markets Ma. Probiotic Market 2014 [cited 7 July 2014]. http://www.marketsandmarkets.com/Market-Reports/probiotic-market-advanced-technologiesand-global-market-69.html.
38. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; CD003048.
39. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children: updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013; 38:467-476.
40. Szajewska H, Skorka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment Pharmacol Ther 2009; 30:960-961.
41. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002; 109:678-684.
42. Feizizadeh S, Salehi-Abargouei A, Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 2014; 134:e176-e191.
43. Szajewska H, Ruszczynski M, Kolacek S. Meta-analysis shows limited evidence for using Lactobacillus acidophilus LB to treat acute gastroenteritis in children. Acta Paediatr 2014; 103:249-255.
44. Szajewska H, Urbanska M, Chmielewska A, et al.Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes 2014; 5:285-293.
45. Nixon AF, Cunningham SJ, Cohen HW, Crain EF. The effect of Lactobacillus GG on acute diarrheal illness in the pediatric emergency department. Pediatr Emerg Care 2012; 28:1048-1051.
46. Huang YF, Liu PY, Chen YY, et al. Three-combination probiotics therapy in children with salmonella and rotavirus gastroenteritis. J Clin Gastroenterol 2014; 48:37-42.
47. Dinleyici EC, Group PS, Vandenplas Y. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatr 2014; 103:e300-e305.
48. Sindhu KN, Sowmyanarayanan TV, Paul A, et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2014; 58:1107-1115.
49. Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN working group for probiotics and prebiotics. J Pediatr Gastroenterol Nutr 2014; 58:531-539.
50. Parker MW, Schaffzin JK, Lo Vecchio A, et al. Rapid adoption of Lactobacillus rhamnosus GG for acute gastroenteritis. Pediatrics 2013; 131:S96-S102.
51. Freedman SB, Williamson-Urquhart S, Schuh S, et al. Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial. Trials 2014; 15:170.
52. Freedman SB, Eltorky M, Gorelick M; Pediatric Emergency Research Canada Gastroenteritis Study Group. Evaluation of a gastroenteritis severity score for use in outpatient settings. Pediatrics 2010; 125:e1278-e1285.
53. Schnadower D, Tarr PI, Gorelick MH, et al. Validation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departments. J Pediatr Gastroenterol Nutr 2013; 57:514-519.
54. Floch MH. Probiotic safety and risk factors. J Clin Gastroenterol 2013; 47:375-376.
55. LeLorier J, Gregoire G, Benhaddad A, et al. Discrepancies between metaanalyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337:536-542.
56. Villar J, Carroli G, Belizan JM. Predictive ability of meta-analyses of randomised controlled trials. Lancet 1995; 345:772-776.
57. Allen SJ, Wareham K, Wang D, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebocontrolled, multicentre trial. Lancet 2013; 382:1249-1257.
58. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and metaanalysis. JAMA 2012; 307:1959-1969.
59. Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and metaanalysis. Ann Intern Med 2012; 157:878-888.
60. Goldenberg JZ, Ma SS, Saxton JD, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2013; 5:CD006095.
61. Washington AE, Lipstein SH. The Patient-Centered Outcomes Research Institute: promoting better information, decisions, and health. N Engl J Med 2011; 365:e31.
62. ClinicalTrials.gov. Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis 2014 [cited 1 June 2014]. http://clinicaltrials.gov/ct2/show/NCT01773967.